Biogen agrees to pay $22m to settle kickback allegations
December 18, 2020Medical Communications Biogen, multiple sclerosis
Biogen has agreed to pay $22 million to put an end to an investigation into claims that it illegally used …
Samsung Biologics names John Rim as CEO and President
December 17, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Samsung BioLogics
Samsung Biologics has appointed John Rim as the company’s President and CEO. The appointment was made effective immediately and formalised via the …
Pharmafile.com’s weekly COVID-19 news round-up
December 17, 2020Developments in the race to vaccinate against COVID-19 have dominated the news this week; a vaccine roll-out is underway in …
European approval for Kite’s CAR-T therapy Tecartus in elapsed or refractory mantle cell lymphoma
December 17, 2020Sales and Marketing CAR-T, Europe, Gilead, Kite, Tecartus
Gilead-owned Kite Therapeutics has secured marketing authorisation from the European Commission for its chimeric antigen receptor (CAR) T cell therapy …
Novavax secures deal with New Zealand for 10.7m doses of COVID-19 vaccine
December 17, 2020Sales and Marketing COVID-19, Novavax, Vaccine
Novavax has announced an Advance Purchase Agreement with New Zealand for the purchase of 10.7 million doses of NVX-CoV2373, the …
FDA says Pfizer vaccine vials contain extra doses, boosting US supply
December 17, 2020Sales and Marketing COVID-19, FDA, Pfizer, Vaccine
The FDA has announced that extra doses contained in Pfizer COVID-19 vaccine vials could expand America’s supply of the jab …
Novartis acquires Cadent Therapeutics in potential $770 million deal
December 17, 2020Sales and Marketing Cadent, Novartis, acquisition
Novartis has sealed an agreement with Cadent Therapeutics to acquire the firm in a deal worth up to $770 million, …
NICE recommends Novartis’ Beovu for wet age-related macular degeneration
December 16, 2020Research and Development NICE, Novartis, wet AMD Beovu
NICE has published its final appraisal of Novartis’ Beovu (brolucizumab), recommending that the drug be made available via the NHS …
Quarter of the world may not access COVID-19 vaccine until 2022
December 16, 2020Research and Development COVID-19, Vaccine
Almost a quarter of the world’s population may not have access to a COVID-19 vaccine until 2022, according to a …
AbbVie buys COVID-19 antibody licence from Harbour BioMed
December 16, 2020Research and Development AbbVie, COVID-19, Harbour BioMed, antibody
Harbour BioMed (HBM) and Utrecht University (UU) have announced that their fully human, SARS-CoV-2 neutralising antibody 47D11 and programme, has …
FDA panel backs Novartis’ Entresto for different form of heart disease
December 16, 2020Research and Development FDA, Novartis, heart failure
Novartis’ heart failure drug Entresto has received recommendation from the FDA’s Cardiovascular and Renal Drugs Advisory Committee for use in …
Eli Lilly scoops up gene therapy specialist Prevail Therapeutics for a potential $1.04bn
December 16, 2020Research and Development, Sales and Marketing Eli Lilly, Prevail, acquisition
Eli Lilly has struck a deal to acquire Prevail Therapeutics in a transaction that could be valued at up to …
How COVID-19 is affecting diabetics and their access to insulin in America
December 15, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Diabetic patients face daily challenges of treatment access and treatment management, so 2020 has been a particularly challenging year. Conor …
EMA panel recommends label extension of AstraZeneca’s Imfinzi in non-small cell lung cancer
December 15, 2020Manufacturing and Production, Sales and Marketing AstraZeneca, Europe, Imfinzi, NSCLC
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has backed a new dosing regimen of AstraZeneca’s …
UAE rolls out Sinopharm COVID-19 vaccine amid conflicting reports of efficacy
December 15, 2020Manufacturing and Production, Research and Development COVID-19, China, Sinopharm, UAE, coronavirus
The United Arab Emirates has begun rolling out Sinopharm’s COVID-19 vaccine in its capital Abu Dhabi, despite claims that numerous …
Final control point analysis shows 90% efficacy for Russia’s Sputnik V COVID-19 vaccine
December 15, 2020Manufacturing and Production, Research and Development COVID-19, Sputnik V, Vaccine
Efficacy data have been revealed from the final control point data analysis for Russia’s Sputnik V COVID-19 vaccine, showing the …
New coronavirus strain identified in the UK
December 15, 2020Manufacturing and Production, Research and Development COVID-19, UK, coronavirus, vaccines
A new variant of coronavirus has been identified in the UK, and is growing faster in some parts of England, …
PPAs – Ready to make a long-term commitment to zero carbon?
December 14, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Energy, sustainability
As an industry that consumes a large amount of energy, the pressure is on for the pharmaceutical sector to achieve …
PPAs – Ready to make a long-term commitment to zero carbon?
December 14, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Energy, sustainability
As an industry that consumes a large amount of energy, the pressure is on for the pharmaceutical sector to achieve …
FDA issues emergency use authorisation for Pfizer-BioNTech vaccine
December 14, 2020Sales and Marketing COVID-19, FDA, US, Vaccine
The US Food and Drug Administration has approved the Pfizer-BioNTech COVID-19 vaccine for emergency use in those aged 16 and …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
Alcami appoints Will Isom to lead laboratory services sales
